Pages without language links

Jump to navigation Jump to search

The following pages do not link to other language versions.

Showing below up to 50 results in range #41 to #90.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Archived: 2010 - 2011 fMRI Reproducibility Call Summaries
  2. Archived: 2010 COPD/Asthma Call Summaries
  3. Archived: 2011 COPD/Asthma Call Summaries
  4. Archived: 2011 CT Volumetry - Group 3A Call Summaries
  5. Archived: 2012 CT Volumetry - Group 3A Call Summaries
  6. Archived: 2012 QIBA US SWS Technical Committee call summaries
  7. Archived: 2012 fMRI Reproducibility Call Summaries
  8. Archived: 2013 fMRI Bias WG Call Summaries
  9. Archived: 2014 fMRI Bias WG Call Summaries
  10. Archived: 2016 Lung Density BC Call Summaries
  11. Archived: fMRI Bias WG Call Summaries
  12. Archived: fMRI Reproducibility Call Summaries
  13. Archived "What is a Profile?" description as of 08.19.2011
  14. Archived - 2010-2011 fMRI Reproducibility Call Summaries
  15. Archived - 2011 fMRI Reproducibility Call Summaries
  16. Archived DCE-MRI Profiles
  17. Archived Versions
  18. Archived Versions of QIBA Vol CT - Group 3A draft documents
  19. Assessment Procedure Guidance
  20. Atherosclerosis Biomarkers Profile Draft Archive
  21. Balloting Process
  22. Bobby test
  23. CEUS BC Call Summaries
  24. CEUS Task Force (TF) Call Summaries
  25. COPD Group Call Summaries
  26. CTV-AD Considerations for Future Editions
  27. CT Acquisition Protocol Groundwork
  28. CT Angiography Biomarker Ctte
  29. CT Angiography Call Summaries Archive
  30. CT Angiography Profile Draft Archive
  31. CT Coordinating Committee
  32. CT Draft Proffered Protocols
  33. CT Small Lung Nodule Biomarker Ctte
  34. CT Volumetry BC Call Summaries Archive
  35. CT Volumetry Biomarker Ctte
  36. Call Agenda Topics
  37. Call Summaries
  38. Call Summaries Archive
  39. Catalog
  40. Change Tracking and File Naming
  41. Claim Confirmation Process
  42. Claim Guidance
  43. Claim Language/Detail
  44. Clinical Applications and Biological Targets Subcommittee
  45. Clinical Sites
  46. Clinical Trial Planning
  47. Clinical Trials Collaboration
  48. Columbia University Medical Center
  49. Combined: System Dependencies & Phantom Development Subcommittees
  50. Combined Nuclear Medicine Biomarker Committee Call Summaries

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)